🔎 Trials Near Me

መነሻ › Metastatic Cancer › ፍሎሪዳ › Orlando

በOrlando፣ FL ለMetastatic Cancer የሚደረጉ ክሊኒካዊ ጥናቶች

ለMetastatic Cancer የሚደረጉ 29 ጥናቶች በOrlando እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07193511

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Advent Health, Orlando
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • AdventHealth Cancer Institute, Orlando
እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06586957

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • AdventHealth Orlando, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT06943755

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07277413

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Altamonte Springs · 9 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06103864

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Florida Cancer Specialists, Orlando
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • እና 4 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07222566

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • AdventHealth Orlando, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • AdventHealth Orlando, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • AdventHealth Altamonte Springs, Altamonte Springs · 9 ማይል ርቀት
  • Clermont Oncology Center, Clermont · 24 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • Orlando Health Orlando Regional Medical Center, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07227415

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Clinical Study Site, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Orlando Health Cancer Institute, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07038343

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Advent Health - Orlando, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT06072612

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT04913285

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Adventhealth, Celebration · 17 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT06803680

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Orlando Health, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Advent Health, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT05614739

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Orlando
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ጁላይ 2026 · NCT07044336

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Orlando Health UF Health Cancer Center, Orlando
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ጁላይ 2026 · NCT05533697

A Study of LY4175408 in Participants With Advanced Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT07046923

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Orlando Health Cancer Institute, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ጁን 2026 · NCT05208047

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Research Site, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT06835569

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • AdventHealth Medical Group Oncology & Hematology at Orlando, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ኤፕሪ 2026 · NCT06064877

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Florida Cancer Specialists, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኤፕሪ 2026 · NCT05735080

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • AdventHealth Cancer Institute, Celebration · 17 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ማርች 2026 · NCT05948865

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Florida Cancer Specialists-Lake Nona, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ፌብሩ 2026 · NCT07030257

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Florida Cancer Specialists, Orlando
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ዲሴም 2025 · NCT06108050

በሌሎች ከተሞች ለMetastatic Cancer የሚደረጉ ጥናቶች

በOrlando ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።